Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Avecho.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s health powerplays: What to look for this earnings season
News
Rise and Shine: What you need to know before the ASX opens
Experts
ScoPo’s powerplays: Jazz Pharma’s $9.4b deal highlights pot plays
Health & Biotech
‘Pure biotech’ play Avecho is making a ‘terrifying’ move. Will it pay off?
Health & Biotech
Check Up: Rhythm Biosciences shares just keep on soaring
News
Winners Column: Here are the top 50 ASX small cap stocks for December
News
Weekly ASX small cap wrap: Who’s at the top of their game?
Health & Biotech
Check Up: Joining ‘observational study’ sends Avecho shares soaring
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Check Up: Avecho leads the ASX healthcare stocks with progress on Propofol
News
ASX Small Cap Lunch Wrap: Gird your loins investors, it’s election day
News
10 at 10: These ASX stocks have made landfall this morning
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
10 at 10: These ASX stocks are marching undeterred this morning
Health & Biotech
Check up: COVID-19 still sells but investors are looking for the next endorphin hit
Health & Biotech
Check up: Pot, takeovers, and COVID-19 are making investors happy
News